Literature DB >> 12414085

Visual object processing in schizophrenia: evidence for an associative agnosic deficit.

Vania S Gabrovska1, Keith R Laws, Julie Sinclair, Peter J McKenna.   

Abstract

Early studies suggested visual form perception impairment in schizophrenia. To re-examine this claim and characterise the deficit neuropsychologically, 41 schizophrenic patients were administered tests sensitive to different levels of visual object perception and recognition. Intellectually well-preserved patients were examined separately on these and additional tests. Single case analysis was also applied to four patients showing varying degrees of general intellectual impairment. As a group, the patients showed little impairment on tests of early visual object perception, but greater impairment on higher-level visual processing tests, in particular object recognition and naming. This held true for patients with preserved general intellectual function. Single case analysis suggested that patients with schizophrenia have a selective deficit affecting object recognition and identification, with a pattern similar to visual associative agnosia in neurological patients. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Year:  2003        PMID: 12414085     DOI: 10.1016/s0920-9964(02)00168-8

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  7 in total

1.  Object versus spatial visual mental imagery in patients with schizophrenia.

Authors:  André Aleman; Edward H F de Haan; René S Kahn
Journal:  J Psychiatry Neurosci       Date:  2005-01       Impact factor: 6.186

2.  Investigating the mechanisms of hallucinogen-induced visions using 3,4-methylenedioxyamphetamine (MDA): a randomized controlled trial in humans.

Authors:  Matthew J Baggott; Jennifer D Siegrist; Gantt P Galloway; Lynn C Robertson; Jeremy R Coyle; John E Mendelson
Journal:  PLoS One       Date:  2010-12-02       Impact factor: 3.240

Review 3.  Visual agnosia.

Authors:  I Biran; H B Coslett
Journal:  Curr Neurol Neurosci Rep       Date:  2003-11       Impact factor: 5.081

4.  Visual form perception: a comparison of individuals at high risk for psychosis, recent onset schizophrenia and chronic schizophrenia.

Authors:  D Kimhy; C Corcoran; J M Harkavy-Friedman; B Ritzler; D C Javitt; D Malaspina
Journal:  Schizophr Res       Date:  2007-09-19       Impact factor: 4.939

Review 5.  A conceptual and practical guide to the behavioural evaluation of animal models of the symptomatology and therapy of schizophrenia.

Authors:  Benjamin K Yee; Philipp Singer
Journal:  Cell Tissue Res       Date:  2013-04-12       Impact factor: 5.249

6.  A Natural Product with High Affinity to Sigma and 5-HT7 Receptors as Novel Therapeutic Drug for Negative and Cognitive Symptoms of Schizophrenia.

Authors:  Lien Wang; Yan Zhang; Chaoran Wang; Xiuli Zhang; Zhiwei Wang; Xinmiao Liang; Amal Alachkar; Olivier Civelli
Journal:  Neurochem Res       Date:  2019-09-16       Impact factor: 3.996

7.  A Methionine-Induced Animal Model of Schizophrenia: Face and Predictive Validity.

Authors:  Lien Wang; Amal Alachkar; Nayna Sanathara; James D Belluzzi; Zhiwei Wang; Olivier Civelli
Journal:  Int J Neuropsychopharmacol       Date:  2015-05-19       Impact factor: 5.176

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.